This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Eagle Pharmaceuticals’s 8K filing here.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc, a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma.
Recommended Stories
- Five stocks we like better than Eagle Pharmaceuticals
- Canada Bond Market Holiday: How to Invest and Trade
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- 10 Best Airline Stocks to Buy
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What Are Dividends? Buy the Best Dividend Stocks
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
